Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MAK

RBC: MAK · Substrate: MBP · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Abemaciclib95.70.56
Pacritinib90.40.45
Pralsetinib69.80.64
Defactinib54.40.45
Vemurafenib52.10.60
Brigatinib36.80.51
Pexidartinib31.70.63
Fedratinib23.80.58
Sunitinib22.00.52
Entrectinib19.70.67
Midostaurin16.20.50
Alpelisib15.60.72
Dabrafenib14.00.63
Baricitinib13.40.62
Pazopanib12.50.67

Known variants

No variants catalogued.
Open in new tab